Inge Marie Svane, MD, PhD

Professor in Clinical cancer immune therapy and director of the translational research centre
National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Herlev, Denmark, Denmark

Presentation(s):

• 61: Surgical considerations for tumor-infiltrating lymphocyte (TIL) therapy in melanoma: results from a randomized phase 3 trial.

  Thursday, March 21, 2024
  2:07pm – 2:17pm ET